Pharmaceutical composition for inhibiting the growth of cancers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31425

Patent

active

057706166

ABSTRACT:
A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals that comprises a material is disclosed. The particular material used is a 1H-1,2,4-triazole derivative. These compounds can also be used to treat viral infections.

REFERENCES:
patent: 4079062 (1978-03-01), Van Reet et al.
patent: 4160838 (1979-07-01), Van Reet et al.
patent: 4490540 (1984-12-01), Heeres
patent: 5114951 (1992-05-01), King
patent: 5211736 (1993-05-01), Lai
Schwartz, "Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patents with acute promyelocytic leukemia," Biochemical Pharmacology, vol. 50, No. 7, 923-928, (1995).
Copending application of J. B. Camden, Ser. No. 08/473,818 filed Jun. 7, 1995.
Copending application of J. B. Camden, Ser. No. 08/674,180 filed Jul. 16, 1996.
Copending application of J. B. Camden, Ser. No. 08/674,182 filed Jul. 16, 1996.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition for inhibiting the growth of cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for inhibiting the growth of cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for inhibiting the growth of cancers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1395101

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.